Company filings profile · CIK 0001388320
Actinium Pharmaceuticals, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Actinium Pharmaceuticals, Inc. (ATNM): 5 filings in the last 90 days vs 1 in the prior 90 (filing-velocity rising ↑ · 5×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Jun 21, 2026. Source-linked, daily-refreshed.
Material 8-K events — Actinium Pharmaceuticals, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Jun 18, 2026 | Other Events | ↗ |
| May 29, 2026 | Delisting / Listing-Rule Failure; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Feb 13, 2026 | Departure/Election of Directors or Officers | ↗ |
| Nov 26, 2025 | Departure/Election of Directors or Officers; Item 5.07 | ↗ |
| May 9, 2025 | Change in Auditor; Financial Statements and Exhibits | ↗ |
| Nov 27, 2024 | Departure/Election of Directors or Officers; Item 5.07 | ↗ |
| Nov 5, 2024 | Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 5, 2024 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
Watch Actinium Pharmaceuticals, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Jun 18, 2026 | 8-K | Other Events | ↗ |
| May 29, 2026 | 8-K | Delisting / Listing-Rule Failure; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 8, 2026 | 10-Q | QUARTERLY REPORT | ↗ |
| Mar 30, 2026 | 10-K | ANNUAL REPORT | ↗ |
| Mar 26, 2026 | 8-K/A | Item 5.07 | ↗ |
| Feb 13, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| Nov 26, 2025 | 8-K | Departure/Election of Directors or Officers; Item 5.07 | ↗ |
| Nov 14, 2025 | 10-Q | QUARTERLY REPORT | ↗ |
| Nov 5, 2025 | ARS | ARS | ↗ |
| Nov 5, 2025 | DEF 14A | PROXY STATEMENT | ↗ |
| Aug 20, 2025 | 4 | ↗ | |
| Aug 8, 2025 | 10-Q | QUARTERLY REPORT | ↗ |
| Jul 29, 2025 | SCHEDULE 13G/A | ↗ | |
| Jul 16, 2025 | SCHEDULE 13G/A | ↗ | |
| May 9, 2025 | 10-Q | QUARTERLY REPORT | ↗ |
| May 9, 2025 | 8-K | Change in Auditor; Financial Statements and Exhibits | ↗ |
| Apr 2, 2025 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Apr 2, 2025 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Apr 2, 2025 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Apr 2, 2025 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Apr 2, 2025 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Apr 2, 2025 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Apr 2, 2025 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Mar 31, 2025 | 10-K | ANNUAL REPORT | ↗ |
| Nov 27, 2024 | 8-K | Departure/Election of Directors or Officers; Item 5.07 | ↗ |
| Nov 14, 2024 | 10-Q | QUARTERLY REPORT | ↗ |
| Nov 12, 2024 | SC 13G/A | ↗ | |
| Nov 8, 2024 | SC 13G/A | ↗ | |
| Nov 6, 2024 | ARS | FORM ARS | ↗ |
| Nov 5, 2024 | 4 | ↗ | |
| Nov 5, 2024 | 3 | ↗ | |
| Nov 5, 2024 | 8-K | Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits | ↗ |
| Nov 5, 2024 | DEF 14A | PROXY STATEMENT | ↗ |
| Nov 4, 2024 | SC 13G | ↗ | |
| Nov 4, 2024 | SC 13G/A | ↗ | |
| Aug 5, 2024 | 10-Q | QUARTERLY REPORT | ↗ |
| Aug 5, 2024 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Apr 26, 2024 | 10-Q | QUARTERLY REPORT | ↗ |
| Mar 29, 2024 | S-8 | REGISTRATION STATEMENT | ↗ |
| Mar 29, 2024 | 10-K | ANNUAL REPORT | ↗ |